Title:
CIIP Korea - Antibody Oligo Drug - Evaluation and Development of antibody conjugated oligos for targeted therapeutics development
Agreement Value:
$600,000.00
Agreement Date:
Dec 1, 2021 - Dec 31, 2023
Description:
This is part of a CIIP Korea project. It will support the firm to generate a series of novel Antibody Oligo Conjugate (AOC) candidates that target lucrative but untapped therapeutic opportunities, by combining two different biotechnologies: 1) Antibody Drug Conjugate and 2) Oligo Therapeutics. The AOC candidates will be evaluated against important multidimensional variables for successful clinical deployment, including biological activity, stability, ease of production and pharmacokinetics.
Organization:
National Research Council Canada
Expected Results:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Location:
Burnaby, British Columbia, CA V5A 4N4
Reference Number:
172-2021-2022-Q4-984807
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
826908816
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 600,000 dollars.
Amendment Date
Mar 31, 2022
Recipient's Legal Name:
iProgen Biotech Inc.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Canadian International Innovation Program
Program Purpose:
The Canadian International Innovation Program fosters and supports collaborative industrial research and development projects with high potential for commercialization between Canada and partner countries. It also stimulates bilateral science and technology networking and matchmaking activities to further new partnerships and accelerate the commercialization of research and development.
Coverage:
The Canadian International Innovation Program supports industrial R & D partnerships and matchmaking activities between Canadian companies and foreign partners with a view to accelerating commercialization and facilitating market access.